{
    "2018-07-05": [
        [
            {
                "time": "2018-07-06",
                "original_text": "Quest Diagnostics Incorporated (DGX) Ex-Dividend Date Scheduled for July 06, 2018",
                "features": {
                    "keywords": [
                        "Quest Diagnostics",
                        "Ex-Dividend",
                        "Scheduled"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-06",
                "original_text": "Drugmakers try evasion, tougher negotiations to fight new U.S. insurer tactic",
                "features": {
                    "keywords": [
                        "Drugmakers",
                        "evasion",
                        "negotiations",
                        "U.S.",
                        "insurer",
                        "tactic"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-06",
                "original_text": "FOCUS-Drugmakers try evasion, tougher negotiations to fight new U.S. insurer tactic",
                "features": {
                    "keywords": [
                        "Drugmakers",
                        "evasion",
                        "negotiations",
                        "U.S.",
                        "insurer",
                        "tactic"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-06",
                "original_text": "JNK, HCRF: Big ETF Outflows",
                "features": {
                    "keywords": [
                        "JNK",
                        "HCRF",
                        "ETF",
                        "Outflows"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}